Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company focused on transforming breast cancer treatment and prevention, announced the completion of a Type C ...
2d
IDEAYA Biosciences, Inc. (IDYA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
IDEAYA Biosciences, Inc. ( IDYA) Citi Annual Global Healthcare Conference 2025 December 2, 2025 9:00 AM EST ...
Biomarker-activated cancer drug-candidate LP-184 demonstrates encouraging efficacy signals in DNA damage repair deficient ...
The study will test the therapy in lung, colorectal, and head and neck cancer patients with B7H3 and PTK7 mutations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback